Skip Navigation

European Heart Journal 1995 16(Supplement B):75-79; doi:10.1093/eurheartj/16.suppl_B.75
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Francioli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francioli, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

Antibiotic treatment of streptococcal and enterococcal endocarditis: an overview

P. Francioli

Division of Hospital Preventative Medicine and Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois 1011 Lausanne, Switzerland

Correspondence to: Dr P. Francioli, Division of Hospital Preventative Medicine and Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.

The management of streptococcal and enterococcal endocarditis has changed in recent years with the development of effective new regimens that are easier to administer, but resistance to commonly used antibiotics has appeared, especially among enterococci. Beta-lactam antibiotics either alone or in combination are suitable for most patients with viridans streptococci. Streptococci bovis, and S. pneumoniae, but alternative regimens are necessary for special situations. Group B, C and G streptococci respond best to the combination of a penicillin and an aminoglycoside.

Enterococci are relatively resistant to penicillins and cephalosporins and strains resistant to beta-lactams, glycopeptides and aminoglycosides have become more common lately. Strategies are proposed dependent on the resistance of the organisms, but it is recognized that medical failure is not uncommon and surgical removal of the infected valve may be the only curative treatment.

Key Words: Management of endocarditis • resistance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
W. Liu, H. Nakamura, K. Shioji, M. Tanito, S.-i. Oka, M. K. Ahsan, A. Son, Y. Ishii, C. Kishimoto, and J. Yodoi
Thioredoxin-1 Ameliorates Myosin-Induced Autoimmune Myocarditis by Suppressing Chemokine Expressions and Leukocyte Chemotaxis in Mice
Circulation, September 7, 2004; 110(10): 1276 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. K. McCormick, H. Hirt, C. M. Waters, T. J. Tripp, G. M. Dunny, and P. M. Schlievert
Antibodies to a Surface-Exposed, N-terminal Domain of Aggregation Substance Are Not Protective in the Rabbit Model of Enterococcus faecalis Infective Endocarditis
Infect. Immun., May 1, 2001; 69(5): 3305 - 3314.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
E. H. Froeliger and P. Fives-Taylor
Streptococcus parasanguis Fimbria-Associated Adhesin Fap1 Is Required for Biofilm Formation
Infect. Immun., April 1, 2001; 69(4): 2512 - 2519.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.